Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Preferred Stock Liabilities (2019 - 2020)

Silo Pharma (SILO) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $400000.0 as the latest value for Q2 2020.

  • Quarterly Preferred Stock Liabilities changed 0.0% to $400000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Jun 2020, changed 0.0% year-over-year, with the annual reading at $400000.0 for FY2019, N/A changed from the prior year.
  • Preferred Stock Liabilities hit $400000.0 in Q2 2020 for Silo Pharma, roughly flat from $400000.0 in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $400000.0 in Q1 2019 to a low of $400000.0 in Q1 2019.